Ensign Peak Advisors, Inc Pacific Biosciences Of California, Inc. Transaction History

Ensign Peak Advisors, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$3.52 - $9.59 $16,410 - $44,708	4,662 Added 4.99%	98,112 $367,000
Q4 2023 Feb 14, 2024	BUY	$5.97 - $10.36 $72,237 - $125,356	12,100 Added 14.87%	93,450 $916,000
Q4 2022 Feb 13, 2023	BUY	$5.67 - $11.2 $205,254 - $405,440	36,200 Added 80.18%	81,350 $665,000
Q4 2021 Feb 11, 2022	BUY	$19.26 - $30.08 $869,589 - $1.36 Million	45,150 New	45,150 $924,000

254

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $438M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ensign Peak Advisors, Inc with notifications on news.